Trial intelligence / Profile preview

White Button Mushroom Supplement in Prostate Cancer

NCT04519879Phase 2Suspended

Sponsor
City of Hope
Start
May 2021
Primary completion
Mar 2026
Modality
Botanical Extract
Countries
1
01

Overview

Phase 2, randomised, open-label trial in prostate cancer (PCa) (4 arms), sponsored by City of Hope. Primary endpoints: Prostate-specific antigen levels at 12 weeks and Relative change in Prostate-specific antigen at 48 weeks. Started May 2021; status: suspended.

02

Conditions

prostate cancer (PCa)

Beyond the preview

Go deeper on NCT04519879.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04519879.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call